Pancreatic Cancer Research

ResearcherYamagata UniversityActive in the last 2 years

Masahiro Yamamoto

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-0652-6105; OpenAlex author ID A5061160958. Sources: OpenAlex.

Their work

Papers
3 (first author 0, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
16
Papers, trials and grants by year

2019: 1 paper · 2020: 1 paper · 2021: none · 2022: none · 2023: none · 2024: 1 paper

Papers 3

  1. MicroRNA-20a in extracellular vesicles derived from duodenal fluid is a possible biomarker for pancreatic ductal adenocarcinoma. Co-author DOI 10.1002/deo2.333↗
  2. Therapeutic targeting of pancreatic cancer stem cells by dexamethasone modulation of the MKP-1-JNK axis. Co-author DOI 10.1074/jbc.ra120.015223↗
  3. Brexpiprazole Reduces Survivin and Reverses EGFR Tyrosine Kinase Inhibitor Resistance in Lung and Pancreatic Cancer. Last author DOI 10.21873/anticanres.13667↗

Closest collaborators

The 16 strongest of 16 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Chifumi Kitanaka · 2 shared papers, 2019–2020 · strength 0.22
  2. Tomomi Sanomachi · 2 shared papers, 2019–2020 · strength 0.22
  3. Shuhei Suzuki · 2 shared papers, 2019–2020 · strength 0.22
  4. Yoshinao Oda · 1 shared paper, 2024 · strength 0.17
  5. So Nakamura · 1 shared paper, 2024 · strength 0.17
  6. Masafumi Nakamura · 1 shared paper, 2024 · strength 0.17
  7. Kohei Nakata · 1 shared paper, 2024 · strength 0.17
  8. Toshiya Abe · 1 shared paper, 2024 · strength 0.17
  9. Koji Tamura · 1 shared paper, 2024 · strength 0.17
  10. Noboru Ideno · 1 shared paper, 2024 · strength 0.17
  11. Kenoki Ohuchida · 1 shared paper, 2024 · strength 0.17
  12. Naoki Ikenaga · 1 shared paper, 2024 · strength 0.17
  13. Takashi Taniguchi · 1 shared paper, 2024 · strength 0.17
  14. Takao Ohtsuka · 1 shared paper, 2024 · strength 0.17
  15. Atsushi Satō · 1 shared paper, 2020 · strength 0.12
  16. Takashi Yoshioka · 1 shared paper, 2019 · strength 0.10

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.